Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical Studies

Objective: To describe the frequency and spectrum of treatment-related adverse events (TRAEs) of immunotherapy combined with antiangiogenic therapy in patients with melanoma. Methods: This retrospective cohort study included three clinical trials on patients with stage III/IV melanoma treated with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Hui, Wang, Xuan, Lian, Bin, Yan, Xieqiao, Si, Lu, Chi, Zhihong, Sheng, Xinan, Kong, Yan, Mao, Lili, Bai, Xue, Tang, Bixia, Li, Siming, Zhou, Li, Cui, Chuanliang, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630676/
https://www.ncbi.nlm.nih.gov/pubmed/34858178
http://dx.doi.org/10.3389/fphar.2021.747416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630676/
https://www.ncbi.nlm.nih.gov/pubmed/34858178
http://dx.doi.org/10.3389/fphar.2021.747416

Ejemplares similares